Hearing Loss Trial, Recruiting NCT06830187 Sponsor: İbrahim Emir Yeşil Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06830187
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Otosclerosis Group:

  • Adults who have been diagnosed with a condition called otosclerosis, confirmed through hearing tests and clinical assessment
  • People who have high-resolution CT scan images of the ear area and hearing test results available
  • People who have had a specific type of ear surgery (stapedectomy or stapedotomy) to treat their condition
  • People who have bone density measurements and vitamin D blood test results available

Control Group (people without otosclerosis):

  • People who do not have otosclerosis but who have had a CT scan of the ear area taken for another reason
  • People with no history of a type of hearing loss caused by sound not travelling properly through the ear
  • People who have bone density measurements and vitamin D blood test results available

Who may not be able to join:

  • People who have a history of conditions that primarily affect bone health, such as osteoporosis or Paget's disease
  • People who take medications known to affect how the body processes bone, such as bisphosphonates or corticosteroids (a type of steroid)
  • People who have a history of long-term ear infection (chronic otitis media) or who have had previous ear surgeries
  • People who have received radiotherapy (radiation treatment) to the head or neck area

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gamze Atay, Assoc Prof, Hacettepe University

Phone: +905019103056

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
İbrahim Emir Yeşil
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
1 March 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Temporal Bone CT Density Measurements; Pure Tone Audiometry (PTA) Thresholds; Air-Bone Gap (ABG) Measurement; Bone Mineral Density (BMD) Scores; Serum Vitamin D Levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov